go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Reckitt Benckiser Ireland Limited

Reckitt Benckiser Ireland Limited
7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
Telephone: +353 1 468 9200
Fax: +353 1 468 9299
Summary of Product Characteristics last updated on medicines.ie: 17/04/2012
SPC Gaviscon Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   12-Sep-2008
Legal Category:   Supply through pharmacy only

Free-text change information supplied by the pharmaceutical company

Updated to amend section 9 to detail date of last renewal to 03/05/2008
Updated to amend section 10 date of revsion of text to September 2008
Updated on 18/12/2008 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to section 1 - Name of medicinal product
  • Change to section 9 - Date of renewal of authorisation
Date of revision of text on the SPC:   09/2008
Legal Category:   retail sale through pharmacy only

Free-text change information supplied by the pharmaceutical company

all changes as a result of license renwal
Updated on 15/05/2007 and displayed until 18/12/2008
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable effects
  • Change to marketing authorisation holder address
Date of revision of text on the SPC:   02/2007
Legal Category:   retail sale through pharmacy only

Free-text change information supplied by the pharmaceutical company

SECTION 4.8.  Allergic manifestations expanded to include anaphylactic and anaphylactoid reactions.
 
SECTION 7.  Change of marketing authorisation holder address to: 7 Riverwalk, Citywest Business Campus, Dublin 24, Ireland.
Updated on 01/07/2005 and displayed until 15/05/2007
Reasons for adding or updating:
  • Change to section 6.3 - Shelf life
Updated on 20/05/2005 and displayed until 01/07/2005
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 11/08/2004 and displayed until 20/05/2005
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 16/06/2003 and displayed until 11/08/2004
Reasons for adding or updating:
  • New SPC for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Sodium Alginate
   Calcium Carbonate
   Sodium Bicarbonate

Versions

 
17/04/2012 to Current
18/12/2008 to 17/04/2012
15/05/2007 to 18/12/2008
01/07/2005 to 15/05/2007
20/05/2005 to 01/07/2005
11/08/2004 to 20/05/2005
16/06/2003 to 11/08/2004
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo